ESLA
Estrella Immunopharma (ESLA)
$26
About Estrella Immunopharma (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
$1.27
Daily low
$1.20
Price at open
$1.25
52 Week High
$3.15
52 Week Low
$0.78
Market cap
54.2M
Dividend yield
0.00%
Volume
42,868
Avg. volume
47,910
P/E ratio
-3.56
Estrella Immunopharma News
Details
Daily high
$1.27
Daily low
$1.20
Price at open
$1.25
52 Week High
$3.15
52 Week Low
$0.78
Market cap
54.2M
Dividend yield
0.00%
Volume
42,868
Avg. volume
47,910
P/E ratio
-3.56